USPTO trademark

AGC BIOLOGICS

RegisteredUSPTOWord markClass 40Class 42

"AGC BIOLOGICS" is a word mark owned by AGC Inc., filed at the USPTO on July 29, 2022. It is registered and covers classes 40 and 42.

View AGC Inc. portfolio Get this data via the API

Data current as of July 2, 2024Official USPTO record

As filed with the USPTO

Status: Registered; Since July 2, 2024
Filed: July 29, 2022
Registered: July 2, 2024
Expires: Not recorded
Application no.: 97526680
Registration no.: 7434649
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 2 classes

Ownership

Who owns AGC BIOLOGICS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AGC Inc.

Tokyo, Japan

339 trademarks in the portfolioView company

Representative

Jeffrey H. Kaufman

Muncy, Geissler, Olds & Lowe, P.C.

Goods and services

What the mark covers

The products and services AGC BIOLOGICS is filed for, grouped by Nice class.

40Class 40 · Treatment of Materials
Antibody physicochemical fractionation of culture fluid or for cells purification for others, namely, custom manufacture of pharmaceuticals; Antibody physicochemical fractionation of culture fluid or for cells purification for others in the nature of biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; custom manufacture of biopharmaceuticals by pharmaceutical compounders by contract manufacturing organization
42Class 42 · Computer and Scientific Services
Biotechnology research; chemical research; research and development services in the field of antibodies being antibody technology

History

What has happened so far

Steps recorded by the USPTO, newest first.

July 2, 2024Notice of registration confirmation emailed
July 2, 2024Registered-principal register
May 28, 2024Notice of acceptance of statement of use e-mailed
May 28, 2024Allowed principal register - sou accepted
March 19, 2024Statement of use processing complete
March 19, 2024Case assigned to intent to use paralegal
February 27, 2024Use amendment filed
February 27, 2024Teas statement of use received
August 29, 2023Noa e-mailed - sou required from applicant
July 4, 2023Official gazette publication confirmation e-mailed

10 earlier steps on the official record.

FAQ

About AGC BIOLOGICS

Who owns the trademark "AGC BIOLOGICS"?

The USPTO trademark "AGC BIOLOGICS" (application 97526680) is owned by AGC Inc.

What is the status of "AGC BIOLOGICS"?

Its status at the USPTO is: registered.

When was "AGC BIOLOGICS" registered?

It was registered on July 2, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AGC BIOLOGICS and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2ace-fd60-714b-b16f-b4499de02aca
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2ace-fd60-714b-b16f-b4499de02aca",
  "object": "trademark",
  "mark_text": "AGC BIOLOGICS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97526680",
  "filing_date": "2022-07-29",
  "nice_classes": [
    40,
    42
  ],
  "owners": [
    {
      "name": "AGC Inc.",
      "entity_id": "ent_019eb74b-d0a0-715b-96c3-193095310a33"
    }
  ]
}